Approaches to Gene-Directed Enzyme Prodrug Therapy (GDEPT)

This publication has 22 references indexed in Scilit:

• In vivo human carboxylesterase cDNA gene transfer to activate the prodrug CPT-11 for local treatment of solid tumors.
  Journal of Clinical Investigation, 1998
• Mustard Prodrugs for Activation by Escherichia coli Nitroreductase in Gene-Directed Enzyme Prodrug Therapy
  Journal of Medicinal Chemistry, 1997
• The Role of Herpes Simplex Thymidine Kinase Gene Transfer in the Drug Treatment of Brain Tumours
  CNS Drugs, 1996
• Creation of drug-specific herpes simplex virus type 1 thymidine kinase mutants for gene therapy.
  Proceedings of the National Academy of Sciences, 1996
• VDEPT: An enzyme/prodrug gene therapy approach for the treatment of metastatic colorectal cancer
  Advanced Drug Delivery Reviews, 1995
• Expression of the bacterial nitroreductase enzyme in mammalian cells renders them selectively sensitive to killing by the prodrug CB1954
  European Journal Of Cancer, 1995
• DEVELOPMENT AND APPLICATION OF HERPES SIMPLEX VIRUS VECTORS FOR HUMAN GENE THERAPY
  Annual Review of Microbiology, 1995
• Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase.
  Proceedings of the National Academy of Sciences, 1994
• In Vivo Gene Transfer with Retroviral Vector-Producer Cells for Treatment of Experimental Brain Tumors
  Science, 1992
• Targeting of an inducible toxic phenotype in animal cells.
  Proceedings of the National Academy of Sciences, 1988